We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Faron Pharmaceuticals Oy | LSE:FARN | London | Ordinary Share | FI4000153309 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 127.50 | 120.00 | 135.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -28.73M | -0.4177 | -3.05 | 87.7M |
TIDMFARN TIDMAV.
RNS Number : 6404K
Faron Pharmaceuticals Oy
10 July 2017
For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) --------------------------------------------------------------------------------------------------------- 1. Identity of the issuer or Faron Pharmaceuticals Oy the underlying issuer of existing shares to which voting rights are attached: (ii) ----------------------------------------------------------------- -------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): --------------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights -------------------------------------------------------------------- ----------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached -------------------------------------------------------------------- ----------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments -------------------------------------------------------------------- ----------------------------------- An event changing the breakdown of voting rights -------------------------------------------------------------------- ----------------------------------- Other (please specify): ----------------------------------------------------------- ------- ----------------------------------- 3. Full name of person(s) Aviva plc & its subsidiaries subject to the notification obligation: (iii) ------------------------------------------------------------- ------------------------------------------ 4. Full name of shareholder(s) Registered Holder: (if different from 3.):(iv) Chase (GA Group) Nominees Limited 1,414,752* HSBC Global Custody Nominee (UK) Limited 347,410* State Street Nominees Limited 35,452* * denotes direct interest Chase (GA Group) Nominees Limited 71,497 Chase Nominees Limited 41,687 ------------------------------------------------------------- ------------------------------------------ 5. Date of the transaction 05 July 2017 and date on which the threshold is crossed or reached: (v) ------------------------------------------------------------- ------------------------------------------ 6. Date on which issuer 07 July 2017 notified: ------------------------------------------------------------- ------------------------------------------ 7. Threshold(s) that is/are 7% to 6% Change at Combined crossed or Interest Level. Figures are reached: (vi, vii) provided in accordance with provisions of your company articles and not in fulfilment of the requirements of the Transparency Directive. ------------------------------------------------------------- ------------------------------------------ 8. Notified details: -------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) -------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------------- ------------------------------ --------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------------- ------------------ ---------- ------------ ---------------------- ------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------------- ------------------ ---------- ------------ ---------- ---------- ------- ---------- Ordinary Shares FI4000153309 1,910,798 1,910,798 1,797,614 1,797,614 113,184 6.44% 0.41% ------------------ ---------- ------------ ---------- ---------- ------- ---------- B: Qualifying Financial Instruments -------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction -------------------------------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of voting % of voting instrument date Conversion rights that rights (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ------------------- ------------------ ------------------------ ---------------------- ------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ----------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------- Type of financial Exercise Expiration Exercise/ Number of voting % of voting instrument price date Conversion rights instrument rights (xix, (xvii) period refers to xx) (xviii) ------------------ --------- ----------- ------------ ------------------- ---------------- Nominal Delta ------------------ --------- ----------- ------------ ------------------- -------- ------ Total (A+B+C) ----------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights -------------------------------------------------------- ------------------------------------- 1,910,798 6.85% -------------------------------------------------------- ------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) -------------------------------------------------------------------- The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chains of controlled undertakings:- Aviva Investors Global Services Limited: * Aviva plc (Parent Company) * Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) * Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) * Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited) Proxy Voting: -------------------------------------------------------------------- 10. Name of the proxy holder: See Section 4 ------------------------------------------------ ------------------ 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------ ------------------ 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------ ------------------ 13. Additional information: Figures are based on a total number of voting rights of
27,914,544 as per the company's Announcement of 1 June 2017. ------------------------------- --------------------------------- 14. Contact name: Neil Whittaker, Aviva plc ------------------------------- --------------------------------- 15. Contact telephone number: 00 44 1603 684420 ------------------------------- ---------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLDMGMNKGVGNZM
(END) Dow Jones Newswires
July 10, 2017 11:51 ET (15:51 GMT)
1 Year Faron Pharmaceuticals Oy Chart |
1 Month Faron Pharmaceuticals Oy Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions